Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Technology Developed To Visualize Molecules in Motion

By LabMedica International staff writers
Posted on 30 Dec 2008
An innovative X-ray technology has been developed that allows the observation of molecular motion on a time scale never reached before.

The technique was developed by a team of researchers from the Ecole Polytechnique Federale de Lausanne (EPFL; Switzerland) and the Paul Scherrer Institute (PSI; Villigen, Switzerland). More...
Results of the research, led by Prof. Majed Chergui, head of EPFL's laboratory of ultrafast spectroscopy in collaboration with collaborators at PSI, was published online December 11, 2008, in the journal Science.

According to the scientists, this discovery provides a promising approach for the study of chemical and biologic systems. It allows a better determination of the structural evolution of molecules during a chemical reaction. The researchers have applied it to the study of metal-based molecular complexes, which is of high interest for chemical researchers. This could lead to applications in magnetic data storage or solar energy. It also opens new perspectives in biology, because the molecules studied are analogous to the active center in hemoproteins (hemoglobin, myoglobin).

It is possible to follow a cat landing on its feel in real time using a camera with shutter times on the order of tens of milliseconds. To do the same with molecules, 100,000 million times smaller than cats, requires shutter times that are 100,000 million times faster--a few tens of femtoseconds (1 femtosecond is to a second what a second is to 32 million years).

Although there are lasers that permit such shutter speeds, no existing optical techniques can capture the molecular structure. To overcome this limitation, Prof. Chergui's team combined lasers delivering femtosecond pulses of ultraviolet-visible light with a source of femtosecond X-ray pulses, in a technique now known as ultrafast X-ray absorption spectroscopy. "With the extremely short wavelengths of this kind of pulsed radiation, it is possible to observe the molecular structure changes, and thus to obtain precise information about the breaking, the formation, or the transformation of chemical bonds between atoms. And all this, in real time,” explained Prof. Chergui.

To reach this level of accuracy, the researchers required a source of stable and tunable femtosecond X-ray pulses. They found it at the Paul Scherrer Institute, in a collaboration with Dr. Rafael Abela's team. Utilizing the femtosecond X-ray pulses extracted from the Swiss Light Source synchrotron in a technique developed at the PSI, the researchers were able to track in real time a structural change of the molecule in 150 femtoseconds. This method, according to the scientists, should be an excellent modality for analyzing reactions in liquid and disordered environments that characterize many biologic and chemical systems.

Related Links:
Ecole Polytechnique Federale de Lausanne
Paul Scherrer Institute



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automatic CLIA Analyzer
Shine i6000
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.